Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05302921
Title Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's National Research Institute
Indications

Ewing sarcoma

Advanced Solid Tumor

rhabdomyosarcoma

osteosarcoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.